PMID- 31723124 OWN - NLM STAT- MEDLINE DCOM- 20200826 LR - 20210110 IS - 2041-4889 (Electronic) VI - 10 IP - 11 DP - 2019 Nov 13 TI - Artesunate induces mitochondria-mediated apoptosis of human retinoblastoma cells by upregulating Kruppel-like factor 6. PG - 862 LID - 10.1038/s41419-019-2084-1 [doi] LID - 862 AB - Retinoblastoma (RB) is the most common primary intraocular malignancy in children. Intravitreal chemotherapy achieves favorable clinical outcomes in controlling RB vitreous seeds, which are a common reason for treatment failure. Thus, a novel, effective and safe intravitreal chemotherapeutic drug is urgently required. The malaria drug artesunate (ART) recently demonstrated remarkable anticancer effects with mild side effects. The purpose of this study is to investigate the anti-RB efficacy, the underlying mechanism and the intraocular safety of ART. Herein, we verified that ART inhibits RB cell viability and induces cell apoptosis in a dose- and time-dependent manner. Microarray analysis revealed that Kruppel-like factor 6 (KLF6) was upregulated after ART treatment, and this was further confirmed by real-time PCR and western blot assays. Silencing of KLF6 expression significantly reversed ART-induced RB cell growth inhibition and apoptosis. Furthermore, ART activated mitochondria-mediated apoptosis of RB cells, while silencing KLF6 expression significantly inhibited this effect. In murine xenotransplantation models of RB, we further confirmed that ART inhibits RB tumor growth, induces tumor cell apoptosis and upregulates KLF6 expression. In addition, KLF6 silencing attenuates ART-mediated inhibition of tumor growth in vivo. Furthermore, we proved that intravitreal injection of ART in Sprague-Dawley (SD) rats is safe, with no obvious retinal function damage or structural disorders observed by electrophysiology (ERG), fundal photographs, fundus fluorescein angiography (FFA) or optical coherence tomography (OCT) examinations. Collectively, our study revealed that ART induces mitochondrial apoptosis of RB cells via upregulating KLF6, and our results may extend the application of ART to the clinic as an effective and safe intravitreal chemotherapeutic drug to treat RB, especially RB with vitreous seeds. FAU - Yang, Ying AU - Yang Y AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, P. R. China. FAU - Wu, Nandan AU - Wu N AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, P. R. China. FAU - Wu, Yihui AU - Wu Y AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, P. R. China. FAU - Chen, Haoting AU - Chen H AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, P. R. China. FAU - Qiu, Jin AU - Qiu J AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, P. R. China. FAU - Qian, Xiaobing AU - Qian X AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, P. R. China. FAU - Zeng, Jieting AU - Zeng J AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, P. R. China. FAU - Chiu, Kin AU - Chiu K AD - Department of Ophthalmology, The University of Hong Kong, Hong Kong SAR, P. R. China. FAU - Gao, Qianying AU - Gao Q AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, P. R. China. gaoqy@hotmail.com. AD - Department of Ophthalmology, The 2nd Affiliate Hospital, Wenzhou Medical University, Wenzhou, 325000, P. R. China. gaoqy@hotmail.com. FAU - Zhuang, Jing AU - Zhuang J AD - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, P. R. China. zhuangj@mail.sysu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20191113 PL - England TA - Cell Death Dis JT - Cell death & disease JID - 101524092 RN - 0 (Antimalarials) RN - 0 (KLF6 protein, human) RN - 0 (Kruppel-Like Factor 6) RN - 60W3249T9M (Artesunate) SB - IM MH - Animals MH - Antimalarials/pharmacology MH - Apoptosis/drug effects MH - Artesunate/*pharmacology MH - Cell Line, Tumor MH - Cell Proliferation/*drug effects MH - Disease Models, Animal MH - Drug Repositioning MH - Gene Expression Regulation, Neoplastic/drug effects MH - Heterografts MH - Humans MH - Kruppel-Like Factor 6/*genetics MH - Mice MH - Mitochondria/drug effects MH - Rats MH - Retinoblastoma/*drug therapy/genetics/pathology MH - Transcriptional Activation/drug effects PMC - PMC6853908 COIS- The authors declare that they have no conflict of interest. EDAT- 2019/11/15 06:00 MHDA- 2020/08/28 06:00 PMCR- 2019/11/13 CRDT- 2019/11/15 06:00 PHST- 2019/04/11 00:00 [received] PHST- 2019/10/17 00:00 [accepted] PHST- 2019/09/29 00:00 [revised] PHST- 2019/11/15 06:00 [entrez] PHST- 2019/11/15 06:00 [pubmed] PHST- 2020/08/28 06:00 [medline] PHST- 2019/11/13 00:00 [pmc-release] AID - 10.1038/s41419-019-2084-1 [pii] AID - 2084 [pii] AID - 10.1038/s41419-019-2084-1 [doi] PST - epublish SO - Cell Death Dis. 2019 Nov 13;10(11):862. doi: 10.1038/s41419-019-2084-1.